Skip to main content
. 2023 Mar 15;14:1129753. doi: 10.3389/fimmu.2023.1129753

Figure 1.

Figure 1

(A) Anti-S-RBD IgG and (B) neutralizing antibody titers one month (T1) and 5.5 months (T2) after two mRNA vaccine doses and one month after a third dose (T3) according to the group of participants (IR, immune responders. DIR, discordant immune responders).